The E-Prescribing market , with a 23.5% CAGR, is projected to increase from USD 2.381 billion in 2025 to USD 8.449 billion in 2031.
The E-Prescribing market growth is expanding quickly and is supposed to do so sooner rather than later. The expanded use of advanced medical services innovations, government estimates supporting electronic health records (EHRs), and the craving to work on drug security and patient results are driving this development. The E-Prescribing market size is influenced by healthcare organizations' requirements for E-Prescribing systems and solutions. The market's significant participants have huge E-Prescribing market shares, which adds to the general competitiveness and dynamism of the E-Recommending market. As the healthcare sector embraces digital transformation, the e-prescription market growth is poised for ongoing growth and innovation.
Due to the expanded utilization of advanced medical services solutions, the E-Prescribing market size is seeing a significant turn of events and change. The course of electronically delivering and conveying remedy orders between medical services professionals and drug stores is known as e-prescribing. It takes out the requirement for customary paper-based solutions, bringing about a few benefits like expanded drug precision, more noteworthy patient security, and quicker tasks.
The E-Prescribing market growth is growing quickly as medical services associations and suppliers see the advantages of moving from paper-based solutions to electronic frameworks. E-prescribing is ready to assume a basic part in the computerized unrest of medical services, with the possibility to work on understanding healthcare, limit remedy slip-ups, and increment by and large healthcare proficiency.
Increasing Adoption of EHRs and healthcare digitalization initiatives to boost the market:
E-prescribing solutions are in high demand as healthcare digitalization initiatives and electronic health records (EHRs) gain traction. The longing to increase patient security, smooth out work processes, and further develop drug the executive’s productivity is driving this reception.
Cost and effectiveness benefits to further fuel the e-prescribing:
E-prescribing frameworks set aside cash and time by disposing of desk work, decreasing drug botches, and speeding up the remedy cycle. This spurs medical care suppliers to send E-Prescribing advances to improve patient results and upgrade their tasks.
Technological Advancements:
Propels in healthcare innovation, including versatile applications and cloud-based stages, help to drive the E-Prescribing market forward. These innovations take into consideration consistent association with existing medical services frameworks, further developed openness, and constant solution data for both medical services experts and patients.
The market for e-prescribing is segmented by product, delivery mode, end-user, and geography. The product is further segmented into services and solutions. Delivery mode is further segmented into on-premises, cloud-based, and web-based.
North America is expected to be a leading e-prescribing marketplace globally.
North America is the market leader in E-Prescribing, with a significant e-prescribing market share. Several reasons contribute to the region's prominence. For starters, the availability of established healthcare infrastructure and modern healthcare IT systems has aided E-Prescribing solution uptake. Second, government initiatives and legislation encouraging the use of electronic health records (EHRs) and digital prescriptions have spurred industry expansion. Furthermore, a great awareness of the benefits of E-Prescribing among healthcare practitioners and patients has helped to its broad acceptance in North America. Major competitors in the area, as well as alliances and partnerships, have enhanced North America's market position in the E-Prescribing market.
In June 2023, Telecare launched Australia’s first stand-alone e-prescription platform namely “RxPad” which is compliant with Australian Digital Health Agency guidelines. The cloud-based platform enables medical professionals to write off prescriptions without entering into any practice management software and further increases their access to view and edit patient’s prescriptions.
In January 2023, Pharmacy Data is a new solution from Health Gorilla, a leading interoperability platform and Health Information Network (HIN), that makes it simple to access comprehensive prescription history data from most major pharmacies. DrFirst's MedHx Population Risk Management (PRM) system is the driving force behind Pharmacy Data, which delivers deduplicated prescription history from local and national data sources like prescribing data, pharmacy dispensing data, and pharmacy benefits management claims.
Surescripts LLC
DrFirst
athenahealth
NextGen Healthcare, Inc.
McKesson Corporation
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Companies |
|
Report Metric | Details |
E-Prescribing Market Size in 2025 | USD 2.381 billion |
E-Prescribing Market Size in 2030 | USD 7.046 billion |
Growth Rate | CAGR of 24.23% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 – 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in E-Prescribing Market |
|
Customization Scope | Free report customization with purchase |
E-Prescribing Market Segmentation
By Product
Solutions
Services
By Delivery Mode
Web-based
On-premise
Cloud-based
By End-User
Hospitals
Physician Offices
Pharmacies
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others